PCA
RGNX icon

Pallas Capital Advisors’s Regenxbio RGNX Stock Holding History

Pallas Capital Advisors’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Buy
14,616
+1,497
+11% +$12.4K 0.01% 918
2026
Q1 		$110K Sell
13,119
-2,426
-16% -$25.5K ﹤0.01% 797
2025
Q4 		$224K Buy
15,545
+385
+3% +$4.8K 0.01% 783
2025
Q3 		$146K Sell
15,160
-2,247
-13% -$19.9K 0.01% 810
2025
Q2 		$143K Buy
17,407
+6,992
+67% +$58.5K 0.01% 780
2025
Q1 		$74.5K Buy
+10,415
New +$77.5K ﹤0.01% 715

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Pallas Capital Advisors's RGNX Position: Q2 2026 in Review

Pallas Capital Advisors increased its Regenxbio (RGNX) stake by 11% in Q2 2026, buying an estimated $12.4K and bringing the position to 14,616 shares worth $175K. The position accounts for 0.01% of the portfolio, ranked #918.

Pallas Capital Advisors first reported a position in RGNX in Q1 2025 and has held it in 6 quarters since. The position peaked at $224K in Q4 2025. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Pallas Capital Advisors held 14,616 shares of Regenxbio worth $175K as of Q2 2026.
  • Pallas Capital Advisors bought 1,497 Regenxbio shares in Q2 2026, an estimated $12.4K.
  • Regenxbio made up 0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #918 holding.
  • Pallas Capital Advisors first reported a position in Regenxbio in Q1 2025 and has held it in 6 quarters since.
  • Pallas Capital Advisors's Regenxbio position peaked at $224K in Q4 2025.
  • 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.